Tm Bioscience Corporation, a leader in the commercial
genetic testing market, and Luminex Corporation, a leading provider of multiplex
solutions, today announced they have signed a multi-year extension of their partnership
agreement, which grants Tm rights to commercialize DNA-based molecular diagnostics
that operate on Luminex's xMAP technology platform.